Incivility in hospitals: health workers strike back.
Explore the source record for details and available documents.
Attitude of Health Personnel↗
Biomedical subjects
Sébastien Tassy
Publications and source records attributed to Sébastien Tassy.
Deficiencies in disaster funding: disasters less "telegenic" than the tsunami must not be forgotten.
Explore the source record for details and available documents.
Disaster Planning↗
Ethical response to liability crisis.
Explore the source record for details and available documents.
Ethics, Medical↗
US versus MRI in prenatal diagnosis: where are we going?
Explore the source record for details and available documents.
Female↗
Making sense of rising caesarean section rates: trials and speaking with patients take time.
Explore the source record for details and available documents.
Cesarean Section↗
Ethical dimensions of elective primary cesarean delivery.
Explore the source record for details and available documents.
Cesarean Section↗
Fetal reduction from twins to a singleton: selective reduction or partial abortion?
Explore the source record for details and available documents.
Chorion↗
[Drug patents and other ways to protect pharmaceutical research].
Pharmaceutical research constitutes a significant cost for pharmaceutical companies. Because of the importance of the financial investment in research projects, companies must protect their discoveries. There are multiple ways to do this. First, the legal avenue can be divided into three parts: a pharmaceutical company can protect a new drug by a patent, then an additional patent or a secondary patent; moreover, since 1992 in Europe, the pharmaceutical industry has been able to extend a patent by the "Supplementary Protection Certificate" (le Certificat Complémentaire de Protection [CCP]). The nonjuridical way is to use the chiral "switch", which can extend patents close to expiring, thus enhancing profitability.
Drug Industry↗